Medicare Prescription Drug Price Negotiation Act of 2007

From Wikipedia, the free encyclopedia

This article documents proposed legislation that is currently being considered. Information may change rapidly as the course of legislation progresses.

In January 2007, the United States House of Representatives approved HR 4, the Medicare Prescription Drug Price Negotiation Act, a bill to require federal officials to negotiate with drug companies for lower prices for the 23 million senior citizens who have signed up for Medicare's prescription drug coverage. If passed, the law would repeal a ban on letting the government negotiate with manufacturers for lower prices — a provision that was part of the GOP-sponsored 2003 measure which created the prescription drug program.^[1]

[edit] References